JP6445523B2 - 生体分子アジュバントを含むワクチン - Google Patents

Info

Publication number

JP6445523B2

JP6445523B2 JP2016503192A JP2016503192A JP6445523B2 JP 6445523 B2 JP6445523 B2 JP 6445523B2 JP 2016503192 A JP2016503192 A JP 2016503192A JP 2016503192 A JP2016503192 A JP 2016503192A JP 6445523 B2 JP6445523 B2 JP 6445523B2

Authority

JP

Japan

Prior art keywords

antigen

vaccine

sequence

nucleic acid

protein

Prior art date

2013-03-15

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired - Fee Related

Links

• Espacenet
• Global Dossier
• Discuss

• 229960005486 vaccine Drugs 0.000 title claims description 221
• 239000002671 adjuvant Substances 0.000 title claims description 136
• 239000000427 antigen Substances 0.000 claims description 362
• 108091007433 antigens Proteins 0.000 claims description 362
• 102000036639 antigens Human genes 0.000 claims description 362
• 239000012634 fragment Substances 0.000 claims description 318
• 150000007523 nucleic acids Chemical class 0.000 claims description 211
• 102000039446 nucleic acids Human genes 0.000 claims description 124
• 108020004707 nucleic acids Proteins 0.000 claims description 124
• 230000028993 immune response Effects 0.000 claims description 106
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 86
• 125000003729 nucleotide group Chemical group 0.000 claims description 75
• 239000002773 nucleotide Substances 0.000 claims description 74
• 230000001965 increasing effect Effects 0.000 claims description 70
• 241000701806 Human papillomavirus Species 0.000 claims description 25
• 238000004520 electroporation Methods 0.000 claims description 24
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 22
• 206010022000 influenza Diseases 0.000 claims description 20
• 239000013604 expression vector Substances 0.000 claims description 18
• 241000223960 Plasmodium falciparum Species 0.000 claims description 10
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 8
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 7
• 238000007918 intramuscular administration Methods 0.000 claims description 4
• 101100540311 Human papillomavirus type 16 E6 gene Proteins 0.000 claims description 2
• 101000767631 Human papillomavirus type 16 Protein E7 Proteins 0.000 claims description 2
• 230000000890 antigenic effect Effects 0.000 claims description 2
• DLQPMEMYCIGJIM-UHFFFAOYSA-N Adjuvant peptide Natural products CC(NC(=O)CCOC1C(O)C(CO)OC(O)C1NC(=O)C)C(=O)NC(CCC(=O)O)C(=O)N DLQPMEMYCIGJIM-UHFFFAOYSA-N 0.000 claims 1
• 125000003275 alpha amino acid group Chemical group 0.000 claims 1
• BSOQXXWZTUDTEL-QAQREVAFSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-QAQREVAFSA-N 0.000 claims 1
• 108090000623 proteins and genes Proteins 0.000 description 134
• 150000001413 amino acids Chemical group 0.000 description 111
• 102000004169 proteins and genes Human genes 0.000 description 106
• 230000014509 gene expression Effects 0.000 description 87
• 210000004027 cell Anatomy 0.000 description 86
• 108010074328 Interferon-gamma Proteins 0.000 description 84
• 101000713602 Homo sapiens T-box transcription factor TBX21 Proteins 0.000 description 77
• 102100037850 Interferon gamma Human genes 0.000 description 76
• 102100036840 T-box transcription factor TBX21 Human genes 0.000 description 76
• 102100024584 Tumor necrosis factor ligand superfamily member 12 Human genes 0.000 description 76
• 101710097155 Tumor necrosis factor ligand superfamily member 12 Proteins 0.000 description 76
• 101000597780 Mus musculus Tumor necrosis factor ligand superfamily member 18 Proteins 0.000 description 74
• 102100035283 Tumor necrosis factor ligand superfamily member 18 Human genes 0.000 description 74
• 210000001744 T-lymphocyte Anatomy 0.000 description 73
• 101710196623 Stimulator of interferon genes protein Proteins 0.000 description 69
• 102100020715 Fms-related tyrosine kinase 3 ligand protein Human genes 0.000 description 66
• 101710162577 Fms-related tyrosine kinase 3 ligand protein Proteins 0.000 description 66
• 210000001519 tissue Anatomy 0.000 description 66
• 241000699670 Mus sp. Species 0.000 description 61
• 101100445364 Mus musculus Eomes gene Proteins 0.000 description 58
• 101100445365 Xenopus laevis eomes gene Proteins 0.000 description 58
• 238000004519 manufacturing process Methods 0.000 description 56
• 239000013612 plasmid Substances 0.000 description 48
• 108020004414 DNA Proteins 0.000 description 43
• 230000002163 immunogen Effects 0.000 description 40
• 108060003951 Immunoglobulin Proteins 0.000 description 37
• 102000018358 immunoglobulin Human genes 0.000 description 37
• 108091035707 Consensus sequence Proteins 0.000 description 35
• 101710154606 Hemagglutinin Proteins 0.000 description 35
• 101710093908 Outer capsid protein VP4 Proteins 0.000 description 35
• 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 35
• 101710176177 Protein A56 Proteins 0.000 description 35
• 208000006454 hepatitis Diseases 0.000 description 35
• 231100000283 hepatitis Toxicity 0.000 description 35
• 108010002350 Interleukin-2 Proteins 0.000 description 33
• 102000000588 Interleukin-2 Human genes 0.000 description 33
• 108010076504 Protein Sorting Signals Proteins 0.000 description 33
• 239000012530 fluid Substances 0.000 description 32
• 230000024932 T cell mediated immunity Effects 0.000 description 30
• 210000003205 muscle Anatomy 0.000 description 30
• 210000003491 skin Anatomy 0.000 description 30
• 210000000987 immune system Anatomy 0.000 description 29
• 239000000185 hemagglutinin Substances 0.000 description 28
• 230000003053 immunization Effects 0.000 description 28
• 238000002649 immunization Methods 0.000 description 28
• 239000013598 vector Substances 0.000 description 28
• 241000894006 Bacteria Species 0.000 description 27
• 230000028996 humoral immune response Effects 0.000 description 27
• 210000003719 b-lymphocyte Anatomy 0.000 description 26
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 25
• 102000018697 Membrane Proteins Human genes 0.000 description 25
• 108010052285 Membrane Proteins Proteins 0.000 description 25
• 238000002347 injection Methods 0.000 description 25
• 239000007924 injection Substances 0.000 description 25
• 108091026890 Coding region Proteins 0.000 description 24
• 241000725303 Human immunodeficiency virus Species 0.000 description 23
• 108020004705 Codon Proteins 0.000 description 22
• 239000012636 effector Substances 0.000 description 22
• 230000014616 translation Effects 0.000 description 21
• 238000000034 method Methods 0.000 description 20
• 238000013519 translation Methods 0.000 description 20
• 101710132601 Capsid protein Proteins 0.000 description 19
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 19
• 108020001507 fusion proteins Proteins 0.000 description 19
• 102000037865 fusion proteins Human genes 0.000 description 19
• 230000000638 stimulation Effects 0.000 description 19
• 238000001890 transfection Methods 0.000 description 18
• 102100040019 Interferon alpha-1/13 Human genes 0.000 description 17
• 208000035896 Twin-reversed arterial perfusion sequence Diseases 0.000 description 17
• 230000033228 biological regulation Effects 0.000 description 17
• 230000000875 corresponding effect Effects 0.000 description 17
• 238000002255 vaccination Methods 0.000 description 17
• 102000004127 Cytokines Human genes 0.000 description 16
• 108090000695 Cytokines Proteins 0.000 description 16
• HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 16
• 241000282414 Homo sapiens Species 0.000 description 16
• 230000005867 T cell response Effects 0.000 description 16
• 101100038180 Caenorhabditis briggsae rpb-1 gene Proteins 0.000 description 15
• 238000002965 ELISA Methods 0.000 description 15
• 241001465754 Metazoa Species 0.000 description 15
• 210000004988 splenocyte Anatomy 0.000 description 15
• 108010012236 Chemokines Proteins 0.000 description 14
• 102000019034 Chemokines Human genes 0.000 description 14
• 241000711920 Human orthopneumovirus Species 0.000 description 14
• 102000040945 Transcription factor Human genes 0.000 description 14
• 108091023040 Transcription factor Proteins 0.000 description 14
• 201000010099 disease Diseases 0.000 description 14
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
• 108040006849 interleukin-2 receptor activity proteins Proteins 0.000 description 14
• 201000004792 malaria Diseases 0.000 description 14
• 238000004458 analytical method Methods 0.000 description 13
• 239000002953 phosphate buffered saline Substances 0.000 description 13
• 108010057466 NF-kappa B Proteins 0.000 description 12
• 102000003945 NF-kappa B Human genes 0.000 description 12
• 230000004069 differentiation Effects 0.000 description 12
• 238000003780 insertion Methods 0.000 description 12
• 230000037431 insertion Effects 0.000 description 12
• 239000000203 mixture Substances 0.000 description 12
• 108700010070 Codon Usage Proteins 0.000 description 11
• 102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 11
• 102100035100 Transcription factor p65 Human genes 0.000 description 11
• -1 hatched bar) Proteins 0.000 description 11
• 230000004083 survival effect Effects 0.000 description 11
• 238000013518 transcription Methods 0.000 description 11
• 230000035897 transcription Effects 0.000 description 11
• 102100030751 Eomesodermin homolog Human genes 0.000 description 10
• 108091006027 G proteins Proteins 0.000 description 10
• 102000030782 GTP binding Human genes 0.000 description 10
• 108091000058 GTP-Binding Proteins 0.000 description 10
• 241000700721 Hepatitis B virus Species 0.000 description 10
• 241000282412 Homo Species 0.000 description 10
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 10
• 238000002474 experimental method Methods 0.000 description 10
• 244000045947 parasite Species 0.000 description 10
• 101710091045 Envelope protein Proteins 0.000 description 9
• 101001064167 Homo sapiens Eomesodermin homolog Proteins 0.000 description 9
• 101710188315 Protein X Proteins 0.000 description 9
• 206010054094 Tumour necrosis Diseases 0.000 description 9
• 241000700605 Viruses Species 0.000 description 9
• 230000008859 change Effects 0.000 description 9
• 230000000295 complement effect Effects 0.000 description 9
• 210000004443 dendritic cell Anatomy 0.000 description 9
• 238000005516 engineering process Methods 0.000 description 9
• 230000006870 function Effects 0.000 description 9
• 102000004196 processed proteins & peptides Human genes 0.000 description 9
• 230000004044 response Effects 0.000 description 9
• 238000001262 western blot Methods 0.000 description 9
• 241000701022 Cytomegalovirus Species 0.000 description 8
• 241000285387 HBV genotype A Species 0.000 description 8
• 241000285452 HBV genotype B Species 0.000 description 8
• 241000285424 HBV genotype C Species 0.000 description 8
• 241000285366 HBV genotype D Species 0.000 description 8
• 241000285370 HBV genotype E Species 0.000 description 8
• 241000285563 HBV genotype F Species 0.000 description 8
• 241000285576 HBV genotype G Species 0.000 description 8
• 241000285579 HBV genotype H Species 0.000 description 8
• 241000711549 Hepacivirus C Species 0.000 description 8
• 241000699666 Mus <mouse, genus> Species 0.000 description 8
• 108091093105 Nuclear DNA Proteins 0.000 description 8
• 102100040247 Tumor necrosis factor Human genes 0.000 description 8
• 230000004663 cell proliferation Effects 0.000 description 8
• 239000003795 chemical substances by application Substances 0.000 description 8
• 239000003814 drug Substances 0.000 description 8
• 230000012010 growth Effects 0.000 description 8
• 239000002502 liposome Substances 0.000 description 8
• 210000000822 natural killer cell Anatomy 0.000 description 8
• 230000000770 proinflammatory effect Effects 0.000 description 8
• 230000001105 regulatory effect Effects 0.000 description 8
• 239000000523 sample Substances 0.000 description 8
• 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 description 7
• 241000709721 Hepatovirus A Species 0.000 description 7
• 102000008070 Interferon-gamma Human genes 0.000 description 7
• 102000010789 Interleukin-2 Receptors Human genes 0.000 description 7
• 108010038453 Interleukin-2 Receptors Proteins 0.000 description 7
• 108060001084 Luciferase Proteins 0.000 description 7
• 239000005089 Luciferase Substances 0.000 description 7
• 241000282553 Macaca Species 0.000 description 7
• 241000124008 Mammalia Species 0.000 description 7
• 241000699660 Mus musculus Species 0.000 description 7
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 7
• 210000005006 adaptive immune system Anatomy 0.000 description 7
• 230000024245 cell differentiation Effects 0.000 description 7
• 230000010261 cell growth Effects 0.000 description 7
• 230000001413 cellular effect Effects 0.000 description 7
• 230000036755 cellular response Effects 0.000 description 7
• 238000010790 dilution Methods 0.000 description 7
• 239000012895 dilution Substances 0.000 description 7
• 230000000694 effects Effects 0.000 description 7
• 238000009472 formulation Methods 0.000 description 7
• 238000009396 hybridization Methods 0.000 description 7
• 230000005847 immunogenicity Effects 0.000 description 7
• 238000001727 in vivo Methods 0.000 description 7
• 238000011534 incubation Methods 0.000 description 7
• 230000003993 interaction Effects 0.000 description 7
• 230000004048 modification Effects 0.000 description 7
• 238000012986 modification Methods 0.000 description 7
• 238000005457 optimization Methods 0.000 description 7
• 230000037361 pathway Effects 0.000 description 7
• 230000019491 signal transduction Effects 0.000 description 7
• 210000000952 spleen Anatomy 0.000 description 7
• 238000006467 substitution reaction Methods 0.000 description 7
• 238000011282 treatment Methods 0.000 description 7
• 108010041986 DNA Vaccines Proteins 0.000 description 6
• 229940021995 DNA vaccine Drugs 0.000 description 6
• 101710128560 Initiator protein NS1 Proteins 0.000 description 6
• 101710144127 Non-structural protein 1 Proteins 0.000 description 6
• 101710144128 Non-structural protein 2 Proteins 0.000 description 6
• 101710199667 Nuclear export protein Proteins 0.000 description 6
• 230000027455 binding Effects 0.000 description 6
• 238000011260 co-administration Methods 0.000 description 6
• 230000036039 immunity Effects 0.000 description 6
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
• 229960003130 interferon gamma Drugs 0.000 description 6
• 239000000463 material Substances 0.000 description 6
• 230000003287 optical effect Effects 0.000 description 6
• 244000052769 pathogen Species 0.000 description 6
• 230000008488 polyadenylation Effects 0.000 description 6
• 229920001184 polypeptide Polymers 0.000 description 6
• 230000009696 proliferative response Effects 0.000 description 6
• 125000006850 spacer group Chemical group 0.000 description 6
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
• 230000003612 virological effect Effects 0.000 description 6
• 101710118188 DNA-binding protein HU-alpha Proteins 0.000 description 5
• 101710158312 DNA-binding protein HU-beta Proteins 0.000 description 5
• 241000724675 Hepatitis E virus Species 0.000 description 5
• 208000037262 Hepatitis delta Diseases 0.000 description 5
• 241000724709 Hepatitis delta virus Species 0.000 description 5
• 206010028980 Neoplasm Diseases 0.000 description 5
• 102100033019 Tyrosine-protein phosphatase non-receptor type 11 Human genes 0.000 description 5
• 230000004913 activation Effects 0.000 description 5
• 230000005875 antibody response Effects 0.000 description 5
• 230000001461 cytolytic effect Effects 0.000 description 5
• 230000005860 defense response to virus Effects 0.000 description 5
• 230000001419 dependent effect Effects 0.000 description 5
• 238000011161 development Methods 0.000 description 5
• 230000018109 developmental process Effects 0.000 description 5
• 229940079593 drug Drugs 0.000 description 5
• 230000005684 electric field Effects 0.000 description 5
• 230000002068 genetic effect Effects 0.000 description 5
• 230000000670 limiting effect Effects 0.000 description 5
• 150000002632 lipids Chemical class 0.000 description 5
• 230000002101 lytic effect Effects 0.000 description 5
• 230000035800 maturation Effects 0.000 description 5
• 239000013642 negative control Substances 0.000 description 5
• 229920000447 polyanionic polymer Polymers 0.000 description 5
• YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 4
• LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 4
• 241000242722 Cestoda Species 0.000 description 4
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
• 241000233866 Fungi Species 0.000 description 4
• 241000712431 Influenza A virus Species 0.000 description 4
• 101150039699 M2-1 gene Proteins 0.000 description 4
• 241000282560 Macaca mulatta Species 0.000 description 4
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 4
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 4
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
• BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 4
• 102100022203 Tumor necrosis factor receptor superfamily member 25 Human genes 0.000 description 4
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
• 238000003556 assay Methods 0.000 description 4
• 230000004071 biological effect Effects 0.000 description 4
• 239000000872 buffer Substances 0.000 description 4
• 230000007969 cellular immunity Effects 0.000 description 4
• PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
• 230000002708 enhancing effect Effects 0.000 description 4
• 238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 4
• 239000000284 extract Substances 0.000 description 4
• 239000012091 fetal bovine serum Substances 0.000 description 4
• 238000000684 flow cytometry Methods 0.000 description 4
• 244000000013 helminth Species 0.000 description 4
• 230000002209 hydrophobic effect Effects 0.000 description 4
• 230000001939 inductive effect Effects 0.000 description 4
• 208000037798 influenza B Diseases 0.000 description 4
• 238000002955 isolation Methods 0.000 description 4
• 239000006166 lysate Substances 0.000 description 4
• 230000001404 mediated effect Effects 0.000 description 4
• 230000001717 pathogenic effect Effects 0.000 description 4
• 229920002643 polyglutamic acid Polymers 0.000 description 4
• 230000035755 proliferation Effects 0.000 description 4
• 210000002966 serum Anatomy 0.000 description 4
• 239000000243 solution Substances 0.000 description 4
• 229940031439 squalene Drugs 0.000 description 4
• TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 4
• 239000000725 suspension Substances 0.000 description 4
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
• 208000030507 AIDS Diseases 0.000 description 3
• 241000283690 Bos taurus Species 0.000 description 3
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
• 241000196324 Embryophyta Species 0.000 description 3
• 101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 description 3
• 108060003393 Granulin Proteins 0.000 description 3
• 108010034145 Helminth Proteins Proteins 0.000 description 3
• 102000004877 Insulin Human genes 0.000 description 3
• 108090001061 Insulin Proteins 0.000 description 3
• 108010065805 Interleukin-12 Proteins 0.000 description 3
• 101150103632 M2-2 gene Proteins 0.000 description 3
• 101100046559 Mus musculus Tnfrsf12a gene Proteins 0.000 description 3
• 241000187479 Mycobacterium tuberculosis Species 0.000 description 3
• 229930182555 Penicillin Natural products 0.000 description 3
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
• 239000012979 RPMI medium Substances 0.000 description 3
• 108010014401 TWEAK Receptor Proteins 0.000 description 3
• 102000016946 TWEAK Receptor Human genes 0.000 description 3
• 108700009124 Transcription Initiation Site Proteins 0.000 description 3
• 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 description 3
• 230000001580 bacterial effect Effects 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 238000004364 calculation method Methods 0.000 description 3
• 201000011510 cancer Diseases 0.000 description 3
• 239000000969 carrier Substances 0.000 description 3
• 239000002299 complementary DNA Substances 0.000 description 3
• 238000012790 confirmation Methods 0.000 description 3
• 238000010276 construction Methods 0.000 description 3
• 238000002716 delivery method Methods 0.000 description 3
• 238000009826 distribution Methods 0.000 description 3
• 230000036541 health Effects 0.000 description 3
• 238000010185 immunofluorescence analysis Methods 0.000 description 3
• 230000006698 induction Effects 0.000 description 3
• 208000015181 infectious disease Diseases 0.000 description 3
• 208000037797 influenza A Diseases 0.000 description 3
• 230000000977 initiatory effect Effects 0.000 description 3
• 229940125396 insulin Drugs 0.000 description 3
• 239000007788 liquid Substances 0.000 description 3
• 238000002826 magnetic-activated cell sorting Methods 0.000 description 3
• 210000004400 mucous membrane Anatomy 0.000 description 3
• 239000007922 nasal spray Substances 0.000 description 3
• 229940049954 penicillin Drugs 0.000 description 3
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 3
• 230000006337 proteolytic cleavage Effects 0.000 description 3
• 230000002829 reductive effect Effects 0.000 description 3
• 201000004409 schistosomiasis Diseases 0.000 description 3
• 230000028327 secretion Effects 0.000 description 3
• 229960005322 streptomycin Drugs 0.000 description 3
• 239000000758 substrate Substances 0.000 description 3
• 230000001225 therapeutic effect Effects 0.000 description 3
• 230000002103 transcriptional effect Effects 0.000 description 3
• 241000712461 unidentified influenza virus Species 0.000 description 3
• KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
• 241000238876 Acari Species 0.000 description 2
• 208000023275 Autoimmune disease Diseases 0.000 description 2
• 241000193738 Bacillus anthracis Species 0.000 description 2
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 2
• 102100021936 C-C motif chemokine 27 Human genes 0.000 description 2
• 101710112538 C-C motif chemokine 27 Proteins 0.000 description 2
• 241000244203 Caenorhabditis elegans Species 0.000 description 2
• BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
• 240000009258 Camassia scilloides Species 0.000 description 2
• 108090000565 Capsid Proteins Proteins 0.000 description 2
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
• 102100023321 Ceruloplasmin Human genes 0.000 description 2
• 101100532584 Clostridium perfringens (strain 13 / Type A) sspC1 gene Proteins 0.000 description 2
• 102000053602 DNA Human genes 0.000 description 2
• 238000011510 Elispot assay Methods 0.000 description 2
• 241000701832 Enterobacteria phage T3 Species 0.000 description 2
• 241000283073 Equus caballus Species 0.000 description 2
• 241000282326 Felis catus Species 0.000 description 2
• 108700023863 Gene Components Proteins 0.000 description 2
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
• 208000007514 Herpes zoster Diseases 0.000 description 2
• 241000238631 Hexapoda Species 0.000 description 2
• 101100095550 Homo sapiens SENP7 gene Proteins 0.000 description 2
• 101100260031 Homo sapiens TBX21 gene Proteins 0.000 description 2
• 101000610604 Homo sapiens Tumor necrosis factor receptor superfamily member 10B Proteins 0.000 description 2
• 101000679903 Homo sapiens Tumor necrosis factor receptor superfamily member 25 Proteins 0.000 description 2
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
• 108010047761 Interferon-alpha Proteins 0.000 description 2
• 102000006992 Interferon-alpha Human genes 0.000 description 2
• 108090000467 Interferon-beta Proteins 0.000 description 2
• 102000003810 Interleukin-18 Human genes 0.000 description 2
• 108090000171 Interleukin-18 Proteins 0.000 description 2
• 108090000978 Interleukin-4 Proteins 0.000 description 2
• 102000004388 Interleukin-4 Human genes 0.000 description 2
• 101710085938 Matrix protein Proteins 0.000 description 2
• 101710127721 Membrane protein Proteins 0.000 description 2
• 241000244206 Nematoda Species 0.000 description 2
• 102100023050 Nuclear factor NF-kappa-B p105 subunit Human genes 0.000 description 2
• 108090001074 Nucleocapsid Proteins Proteins 0.000 description 2
• 101710141454 Nucleoprotein Proteins 0.000 description 2
• 108091034117 Oligonucleotide Proteins 0.000 description 2
• 241000935974 Paralichthys dentatus Species 0.000 description 2
• 108091005804 Peptidases Proteins 0.000 description 2
• 241000009328 Perro Species 0.000 description 2
• 241001674048 Phthiraptera Species 0.000 description 2
• 229920001213 Polysorbate 20 Polymers 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 2
• 102000000850 Proto-Oncogene Proteins c-rel Human genes 0.000 description 2
• 108010001859 Proto-Oncogene Proteins c-rel Proteins 0.000 description 2
• 108020005067 RNA Splice Sites Proteins 0.000 description 2
• 101150098865 SSP2 gene Proteins 0.000 description 2
• 102100031406 Sentrin-specific protease 7 Human genes 0.000 description 2
• 230000006052 T cell proliferation Effects 0.000 description 2
• 108010091885 T-box transcription factor TBX21 Proteins 0.000 description 2
• 101150056647 TNFRSF4 gene Proteins 0.000 description 2
• 206010043376 Tetanus Diseases 0.000 description 2
• 210000000447 Th1 cell Anatomy 0.000 description 2
• 241000242541 Trematoda Species 0.000 description 2
• 206010044608 Trichiniasis Diseases 0.000 description 2
• YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 2
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
• 241000700647 Variola virus Species 0.000 description 2
• 108010067390 Viral Proteins Proteins 0.000 description 2
• 239000004480 active ingredient Substances 0.000 description 2
• 230000033289 adaptive immune response Effects 0.000 description 2
• 230000004721 adaptive immunity Effects 0.000 description 2
• 238000003491 array Methods 0.000 description 2
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
• 230000003115 biocidal effect Effects 0.000 description 2
• 230000008827 biological function Effects 0.000 description 2
• 230000000903 blocking effect Effects 0.000 description 2
• 210000004204 blood vessel Anatomy 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• 229910001424 calcium ion Inorganic materials 0.000 description 2
• 230000000139 costimulatory effect Effects 0.000 description 2
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 238000010586 diagram Methods 0.000 description 2
• 230000009699 differential effect Effects 0.000 description 2
• 239000000539 dimer Substances 0.000 description 2
• 244000078703 ectoparasite Species 0.000 description 2
• 238000001378 electrochemiluminescence detection Methods 0.000 description 2
• 239000000839 emulsion Substances 0.000 description 2
• 239000003623 enhancer Substances 0.000 description 2
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
• 230000002538 fungal effect Effects 0.000 description 2
• 238000012239 gene modification Methods 0.000 description 2
• 230000005017 genetic modification Effects 0.000 description 2
• 235000013617 genetically modified food Nutrition 0.000 description 2
• 239000001963 growth medium Substances 0.000 description 2
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
• 230000002440 hepatic effect Effects 0.000 description 2
• 229920002674 hyaluronan Polymers 0.000 description 2
• 229960003160 hyaluronic acid Drugs 0.000 description 2
• 230000003308 immunostimulating effect Effects 0.000 description 2
• 230000001976 improved effect Effects 0.000 description 2
• 238000000338 in vitro Methods 0.000 description 2
• 230000002757 inflammatory effect Effects 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• 239000003112 inhibitor Substances 0.000 description 2
• 230000015788 innate immune response Effects 0.000 description 2
• 239000000543 intermediate Substances 0.000 description 2
• DRAVOWXCEBXPTN-UHFFFAOYSA-N isoguanine Chemical compound NC1=NC(=O)NC2=C1NC=N2 DRAVOWXCEBXPTN-UHFFFAOYSA-N 0.000 description 2
• 210000003734 kidney Anatomy 0.000 description 2
• 238000003468 luciferase reporter gene assay Methods 0.000 description 2
• 210000004072 lung Anatomy 0.000 description 2
• 239000012139 lysis buffer Substances 0.000 description 2
• 229920002521 macromolecule Polymers 0.000 description 2
• 210000001616 monocyte Anatomy 0.000 description 2
• 229940035032 monophosphoryl lipid a Drugs 0.000 description 2
• 210000004877 mucosa Anatomy 0.000 description 2
• 125000001446 muramyl group Chemical group N[C@@H](C=O)[C@@H](O[C@@H](C(=O)*)C)[C@H](O)[C@H](O)CO 0.000 description 2
• 210000000066 myeloid cell Anatomy 0.000 description 2
• 239000002105 nanoparticle Substances 0.000 description 2
• 229940097496 nasal spray Drugs 0.000 description 2
• 210000001331 nose Anatomy 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 230000002018 overexpression Effects 0.000 description 2
• 230000003071 parasitic effect Effects 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
• 229920000642 polymer Polymers 0.000 description 2
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
• 239000000843 powder Substances 0.000 description 2
• 239000000047 product Substances 0.000 description 2
• 230000001681 protective effect Effects 0.000 description 2
• 150000004053 quinones Chemical class 0.000 description 2
• 230000009257 reactivity Effects 0.000 description 2
• 230000010076 replication Effects 0.000 description 2
• 150000003839 salts Chemical class 0.000 description 2
• 230000011664 signaling Effects 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 229910001415 sodium ion Inorganic materials 0.000 description 2
• 239000007787 solid Substances 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 238000010186 staining Methods 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 239000004094 surface-active agent Substances 0.000 description 2
• 238000012360 testing method Methods 0.000 description 2
• 229940104230 thymidine Drugs 0.000 description 2
• 229940113082 thymine Drugs 0.000 description 2
• 210000001541 thymus gland Anatomy 0.000 description 2
• 230000005030 transcription termination Effects 0.000 description 2
• 208000003982 trichinellosis Diseases 0.000 description 2
• 201000007588 trichinosis Diseases 0.000 description 2
• 229910052722 tritium Inorganic materials 0.000 description 2
• 238000009827 uniform distribution Methods 0.000 description 2
• 229940035893 uracil Drugs 0.000 description 2
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
• 229940075420 xanthine Drugs 0.000 description 2
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
• 101800001622 120 kDa surface-exposed protein Proteins 0.000 description 1
• NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
• XQCZBXHVTFVIFE-UHFFFAOYSA-N 2-amino-4-hydroxypyrimidine Chemical compound NC1=NC=CC(O)=N1 XQCZBXHVTFVIFE-UHFFFAOYSA-N 0.000 description 1
• UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
• QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 1
• 101710122462 65 kDa protein Proteins 0.000 description 1
• 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
• 241000224422 Acanthamoeba Species 0.000 description 1
• 206010069408 Acanthamoeba keratitis Diseases 0.000 description 1
• 206010063409 Acarodermatitis Diseases 0.000 description 1
• 241000580482 Acidobacteria Species 0.000 description 1
• 241000186046 Actinomyces Species 0.000 description 1
• 229930024421 Adenine Natural products 0.000 description 1
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
• 241000701242 Adenoviridae Species 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 208000004881 Amebiasis Diseases 0.000 description 1
• 206010001935 American trypanosomiasis Diseases 0.000 description 1
• 206010001980 Amoebiasis Diseases 0.000 description 1
• 241000244023 Anisakis Species 0.000 description 1
• 206010059313 Anogenital warts Diseases 0.000 description 1
• 102100030346 Antigen peptide transporter 1 Human genes 0.000 description 1
• 102100030343 Antigen peptide transporter 2 Human genes 0.000 description 1
• 241000712892 Arenaviridae Species 0.000 description 1
• 241000712891 Arenavirus Species 0.000 description 1
• 241000228212 Aspergillus Species 0.000 description 1
• 206010003694 Atrophy Diseases 0.000 description 1
• 241000606125 Bacteroides Species 0.000 description 1
• 241000244183 Baylisascaris procyonis Species 0.000 description 1
• 102100023995 Beta-nerve growth factor Human genes 0.000 description 1
• 241000228405 Blastomyces dermatitidis Species 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• 102100021943 C-C motif chemokine 2 Human genes 0.000 description 1
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 1
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 1
• 108010029697 CD40 Ligand Proteins 0.000 description 1
• 101150013553 CD40 gene Proteins 0.000 description 1
• 102100032937 CD40 ligand Human genes 0.000 description 1
• 108010084313 CD58 Antigens Proteins 0.000 description 1
• 101100289995 Caenorhabditis elegans mac-1 gene Proteins 0.000 description 1
• 241001672012 Caldisericum Species 0.000 description 1
• 241000714198 Caliciviridae Species 0.000 description 1
• 241001493160 California encephalitis virus Species 0.000 description 1
• 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
• 241000222122 Candida albicans Species 0.000 description 1
• 102000011727 Caspases Human genes 0.000 description 1
• 108010076667 Caspases Proteins 0.000 description 1
• 241001070941 Castanea Species 0.000 description 1
• 235000014036 Castanea Nutrition 0.000 description 1
• 102100028906 Catenin delta-1 Human genes 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 208000024699 Chagas disease Diseases 0.000 description 1
• 101710098119 Chaperonin GroEL 2 Proteins 0.000 description 1
• 108010055166 Chemokine CCL5 Proteins 0.000 description 1
• 201000006082 Chickenpox Diseases 0.000 description 1
• 241001502567 Chikungunya virus Species 0.000 description 1
• 241000606161 Chlamydia Species 0.000 description 1
• 241000191368 Chlorobi Species 0.000 description 1
• 241001142109 Chloroflexi Species 0.000 description 1
• 241000238855 Chrysiogenes Species 0.000 description 1
• 241000193163 Clostridioides difficile Species 0.000 description 1
• 241000223203 Coccidioides Species 0.000 description 1
• 241000254173 Coleoptera Species 0.000 description 1
• 102000029816 Collagenase Human genes 0.000 description 1
• 108060005980 Collagenase Proteins 0.000 description 1
• 208000000907 Condylomata Acuminata Diseases 0.000 description 1
• 241000711573 Coronaviridae Species 0.000 description 1
• 201000007336 Cryptococcosis Diseases 0.000 description 1
• 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
• 241000221204 Cryptococcus neoformans Species 0.000 description 1
• 241000192700 Cyanobacteria Species 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• 238000011238 DNA vaccination Methods 0.000 description 1
• 230000004568 DNA-binding Effects 0.000 description 1
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• 241001414892 Delia radicum Species 0.000 description 1
• 241000725619 Dengue virus Species 0.000 description 1
• 206010048768 Dermatosis Diseases 0.000 description 1
• 101710088335 Diacylglycerol acyltransferase/mycolyltransferase Ag85A Proteins 0.000 description 1
• 101710088334 Diacylglycerol acyltransferase/mycolyltransferase Ag85B Proteins 0.000 description 1
• 241000255925 Diptera Species 0.000 description 1
• 108010024212 E-Selectin Proteins 0.000 description 1
• 102100023471 E-selectin Human genes 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 101710130332 ETS domain-containing protein Elk-4 Proteins 0.000 description 1
• 241001115402 Ebolavirus Species 0.000 description 1
• 206010014096 Echinococciasis Diseases 0.000 description 1
• 208000009366 Echinococcosis Diseases 0.000 description 1
• 241000709661 Enterovirus Species 0.000 description 1
• 241000991587 Enterovirus C Species 0.000 description 1
• 101710201246 Eomesodermin Proteins 0.000 description 1
• 208000000832 Equine Encephalomyelitis Diseases 0.000 description 1
• 208000010201 Exanthema Diseases 0.000 description 1
• 241000242711 Fasciola hepatica Species 0.000 description 1
• 241000605898 Fibrobacter Species 0.000 description 1
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
• 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
• 102100031706 Fibroblast growth factor 1 Human genes 0.000 description 1
• 241000711950 Filoviridae Species 0.000 description 1
• 206010016717 Fistula Diseases 0.000 description 1
• 241000710831 Flavivirus Species 0.000 description 1
• 206010016952 Food poisoning Diseases 0.000 description 1
• 208000019331 Foodborne disease Diseases 0.000 description 1
• 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
• 241000223218 Fusarium Species 0.000 description 1
• 241000605909 Fusobacterium Species 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
• 108700010908 HIV-1 proteins Proteins 0.000 description 1
• 206010061192 Haemorrhagic fever Diseases 0.000 description 1
• 239000012981 Hank's balanced salt solution Substances 0.000 description 1
• 101710165610 Heat-stable 19 kDa antigen Proteins 0.000 description 1
• 208000006968 Helminthiasis Diseases 0.000 description 1
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
• 241000700739 Hepadnaviridae Species 0.000 description 1
• 208000005176 Hepatitis C Diseases 0.000 description 1
• 206010019799 Hepatitis viral Diseases 0.000 description 1
• 208000001688 Herpes Genitalis Diseases 0.000 description 1
• 241000228404 Histoplasma capsulatum Species 0.000 description 1
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
• 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 1
• 101000991061 Homo sapiens MHC class I polypeptide-related sequence B Proteins 0.000 description 1
• 101001109503 Homo sapiens NKG2-C type II integral membrane protein Proteins 0.000 description 1
• 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 description 1
• 101000979342 Homo sapiens Nuclear factor NF-kappa-B p105 subunit Proteins 0.000 description 1
• 101000934346 Homo sapiens T-cell surface antigen CD2 Proteins 0.000 description 1
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
• 101100100117 Homo sapiens TNFRSF10B gene Proteins 0.000 description 1
• 101001050288 Homo sapiens Transcription factor Jun Proteins 0.000 description 1
• 101000610602 Homo sapiens Tumor necrosis factor receptor superfamily member 10C Proteins 0.000 description 1
• 101000610609 Homo sapiens Tumor necrosis factor receptor superfamily member 10D Proteins 0.000 description 1
• 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 description 1
• 101000679921 Homo sapiens Tumor necrosis factor receptor superfamily member 21 Proteins 0.000 description 1
• 241000598436 Human T-cell lymphotropic virus Species 0.000 description 1
• 241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
• 101000807958 Human papillomavirus 52 Protein E6 Proteins 0.000 description 1
• 101000622278 Human papillomavirus 52 Protein E7 Proteins 0.000 description 1
• 101000742671 Human papillomavirus 58 Protein E6 Proteins 0.000 description 1
• 101000954519 Human papillomavirus type 18 Protein E6 Proteins 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
• 238000012404 In vitro experiment Methods 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 241000713196 Influenza B virus Species 0.000 description 1
• 229930010555 Inosine Natural products 0.000 description 1
• UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
• 102100034353 Integrase Human genes 0.000 description 1
• 102100025323 Integrin alpha-1 Human genes 0.000 description 1
• 102100022339 Integrin alpha-L Human genes 0.000 description 1
• 102100022338 Integrin alpha-M Human genes 0.000 description 1
• 102100022297 Integrin alpha-X Human genes 0.000 description 1
• 108010041341 Integrin alpha1 Proteins 0.000 description 1
• 108010055795 Integrin alpha1beta1 Proteins 0.000 description 1
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
• 108010064600 Intercellular Adhesion Molecule-3 Proteins 0.000 description 1
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
• 101710148794 Intercellular adhesion molecule 2 Proteins 0.000 description 1
• 102100037872 Intercellular adhesion molecule 2 Human genes 0.000 description 1
• 102100026720 Interferon beta Human genes 0.000 description 1
• 102000003996 Interferon-beta Human genes 0.000 description 1
• 108010002352 Interleukin-1 Proteins 0.000 description 1
• 102000000589 Interleukin-1 Human genes 0.000 description 1
• 102100036342 Interleukin-1 receptor-associated kinase 1 Human genes 0.000 description 1
• 101710199015 Interleukin-1 receptor-associated kinase 1 Proteins 0.000 description 1
• 108090000174 Interleukin-10 Proteins 0.000 description 1
• 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• 108090001005 Interleukin-6 Proteins 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 108090001007 Interleukin-8 Proteins 0.000 description 1
• 102000004890 Interleukin-8 Human genes 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• 108020003285 Isocitrate lyase Proteins 0.000 description 1
• 108010055717 JNK Mitogen-Activated Protein Kinases Proteins 0.000 description 1
• 102000019145 JUN kinase activity proteins Human genes 0.000 description 1
• 101150069255 KLRC1 gene Proteins 0.000 description 1
• 101150074862 KLRC3 gene Proteins 0.000 description 1
• 101150018199 KLRC4 gene Proteins 0.000 description 1
• 108010092694 L-Selectin Proteins 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• 229930182816 L-glutamine Natural products 0.000 description 1
• 102100033467 L-selectin Human genes 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• 241000712902 Lassa mammarenavirus Species 0.000 description 1
• 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
• 241000222722 Leishmania <genus> Species 0.000 description 1
• 208000004554 Leishmaniasis Diseases 0.000 description 1
• 240000007472 Leucaena leucocephala Species 0.000 description 1
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
• 241001541122 Linguatula serrata Species 0.000 description 1
• 241000406668 Loxodonta cyclotis Species 0.000 description 1
• 208000016604 Lyme disease Diseases 0.000 description 1
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 1
• 102000019149 MAP kinase activity proteins Human genes 0.000 description 1
• 108040008097 MAP kinase activity proteins Proteins 0.000 description 1
• 102100030301 MHC class I polypeptide-related sequence A Human genes 0.000 description 1
• 102100030300 MHC class I polypeptide-related sequence B Human genes 0.000 description 1
• 101100404845 Macaca mulatta NKG2A gene Proteins 0.000 description 1
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 241001115401 Marburgvirus Species 0.000 description 1
• 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
• 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
• 241000712079 Measles morbillivirus Species 0.000 description 1
• 108010023335 Member 2 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
• 108010060408 Member 25 Tumor Necrosis Factor Receptors Proteins 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
• 102100028194 Mitogen-activated protein kinase kinase kinase kinase 4 Human genes 0.000 description 1
• 241000713333 Mouse mammary tumor virus Species 0.000 description 1
• 101710164418 Movement protein TGB2 Proteins 0.000 description 1
• 241000711386 Mumps virus Species 0.000 description 1
• 101100372761 Mus musculus Flt1 gene Proteins 0.000 description 1
• 101100294024 Mus musculus Nfkb1 gene Proteins 0.000 description 1
• 101100099157 Mus musculus Rela gene Proteins 0.000 description 1
• 101100260032 Mus musculus Tbx21 gene Proteins 0.000 description 1
• 102000010168 Myeloid Differentiation Factor 88 Human genes 0.000 description 1
• 108010077432 Myeloid Differentiation Factor 88 Proteins 0.000 description 1
• 102000008125 NF-kappa B p52 Subunit Human genes 0.000 description 1
• 108010074852 NF-kappa B p52 Subunit Proteins 0.000 description 1
• 102100022682 NKG2-A/NKG2-B type II integral membrane protein Human genes 0.000 description 1
• 102100022683 NKG2-C type II integral membrane protein Human genes 0.000 description 1
• 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 description 1
• 102100022701 NKG2-E type II integral membrane protein Human genes 0.000 description 1
• 102100022700 NKG2-F type II integral membrane protein Human genes 0.000 description 1
• 108010025020 Nerve Growth Factor Proteins 0.000 description 1
• 241000192121 Nitrospira <genus> Species 0.000 description 1
• 101710144111 Non-structural protein 3 Proteins 0.000 description 1
• 241000714209 Norwalk virus Species 0.000 description 1
• 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 description 1
• 102000011931 Nucleoproteins Human genes 0.000 description 1
• 108010061100 Nucleoproteins Proteins 0.000 description 1
• 239000004677 Nylon Substances 0.000 description 1
• 241000243985 Onchocerca volvulus Species 0.000 description 1
• 206010067152 Oral herpes Diseases 0.000 description 1
• 241000150452 Orthohantavirus Species 0.000 description 1
• 241000712464 Orthomyxoviridae Species 0.000 description 1
• 101000793655 Oryza sativa subsp. japonica Calreticulin Proteins 0.000 description 1
• 102100034574 P protein Human genes 0.000 description 1
• 101710181008 P protein Proteins 0.000 description 1
• 108010035766 P-Selectin Proteins 0.000 description 1
• 102100023472 P-selectin Human genes 0.000 description 1
• 101150044441 PECAM1 gene Proteins 0.000 description 1
• 241000282577 Pan troglodytes Species 0.000 description 1
• 241001631646 Papillomaviridae Species 0.000 description 1
• 206010033799 Paralysis Diseases 0.000 description 1
• 241000711504 Paramyxoviridae Species 0.000 description 1
• 241000701945 Parvoviridae Species 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 241000150350 Peribunyaviridae Species 0.000 description 1
• 101710177166 Phosphoprotein Proteins 0.000 description 1
• 108010089430 Phosphoproteins Proteins 0.000 description 1
• 102000007982 Phosphoproteins Human genes 0.000 description 1
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
• 241000709664 Picornaviridae Species 0.000 description 1
• 241000233870 Pneumocystis Species 0.000 description 1
• 101710182846 Polyhedrin Proteins 0.000 description 1
• 241000192142 Proteobacteria Species 0.000 description 1
• 102100028688 Putative glycosylation-dependent cell adhesion molecule 1 Human genes 0.000 description 1
• 102000014128 RANK Ligand Human genes 0.000 description 1
• 108010025832 RANK Ligand Proteins 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• 241000711798 Rabies lyssavirus Species 0.000 description 1
• 101710138742 Receptor-type tyrosine-protein phosphatase H Proteins 0.000 description 1
• 208000015634 Rectal Neoplasms Diseases 0.000 description 1
• 241000702247 Reoviridae Species 0.000 description 1
• 108700008625 Reporter Genes Proteins 0.000 description 1
• 241000712907 Retroviridae Species 0.000 description 1
• 241000711931 Rhabdoviridae Species 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 241000714474 Rous sarcoma virus Species 0.000 description 1
• 241000710799 Rubella virus Species 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 241000607142 Salmonella Species 0.000 description 1
• 102400000830 Saposin-B Human genes 0.000 description 1
• 241000447727 Scabies Species 0.000 description 1
• 206010040070 Septic Shock Diseases 0.000 description 1
• 102100021225 Serine hydroxymethyltransferase, cytosolic Human genes 0.000 description 1
• 241000258242 Siphonaptera Species 0.000 description 1
• 108020004459 Small interfering RNA Proteins 0.000 description 1
• FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
• 241001149962 Sporothrix Species 0.000 description 1
• 241000295644 Staphylococcaceae Species 0.000 description 1
• 241000191967 Staphylococcus aureus Species 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 241000282898 Sus scrofa Species 0.000 description 1
• 241000206598 Synergistes Species 0.000 description 1
• 108700005078 Synthetic Genes Proteins 0.000 description 1
• 230000006044 T cell activation Effects 0.000 description 1
• 208000000389 T-cell leukemia Diseases 0.000 description 1
• 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 1
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
• 101150074137 TBX21 gene Proteins 0.000 description 1
• 102000003714 TNF receptor-associated factor 6 Human genes 0.000 description 1
• 108090000009 TNF receptor-associated factor 6 Proteins 0.000 description 1
• 101800000849 Tachykinin-associated peptide 2 Proteins 0.000 description 1
• 241000204652 Thermotoga Species 0.000 description 1
• 241000710924 Togaviridae Species 0.000 description 1
• 102000002689 Toll-like receptor Human genes 0.000 description 1
• 108020000411 Toll-like receptor Proteins 0.000 description 1
• 206010044269 Toxocariasis Diseases 0.000 description 1
• 241000223996 Toxoplasma Species 0.000 description 1
• 201000005485 Toxoplasmosis Diseases 0.000 description 1
• 102100023132 Transcription factor Jun Human genes 0.000 description 1
• 108700019146 Transgenes Proteins 0.000 description 1
• 241000223104 Trypanosoma Species 0.000 description 1
• 241000223109 Trypanosoma cruzi Species 0.000 description 1
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
• 102100040115 Tumor necrosis factor receptor superfamily member 10C Human genes 0.000 description 1
• 102100040110 Tumor necrosis factor receptor superfamily member 10D Human genes 0.000 description 1
• 102100022205 Tumor necrosis factor receptor superfamily member 21 Human genes 0.000 description 1
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
• 108090000848 Ubiquitin Proteins 0.000 description 1
• 102000044159 Ubiquitin Human genes 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 241000700618 Vaccinia virus Species 0.000 description 1
• 206010046980 Varicella Diseases 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 101150003160 X gene Proteins 0.000 description 1
• 241000710772 Yellow fever virus Species 0.000 description 1
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 229960000643 adenine Drugs 0.000 description 1
• 108700010877 adenoviridae proteins Proteins 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 229940008126 aerosol Drugs 0.000 description 1
• 238000013019 agitation Methods 0.000 description 1
• 208000026935 allergic disease Diseases 0.000 description 1
• 230000007815 allergy Effects 0.000 description 1
• AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 208000025009 anogenital human papillomavirus infection Diseases 0.000 description 1
• 201000004201 anogenital venereal wart Diseases 0.000 description 1
• 230000030741 antigen processing and presentation Effects 0.000 description 1
• 210000004436 artificial bacterial chromosome Anatomy 0.000 description 1
• 210000001106 artificial yeast chromosome Anatomy 0.000 description 1
• 208000006673 asthma Diseases 0.000 description 1
• 230000037444 atrophy Effects 0.000 description 1
• 108010088716 attachment protein G Proteins 0.000 description 1
• 201000008680 babesiosis Diseases 0.000 description 1
• 244000052616 bacterial pathogen Species 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 238000004422 calculation algorithm Methods 0.000 description 1
• 229940095731 candida albicans Drugs 0.000 description 1
• 229910002092 carbon dioxide Inorganic materials 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000020411 cell activation Effects 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 230000009087 cell motility Effects 0.000 description 1
• 238000001516 cell proliferation assay Methods 0.000 description 1
• 230000009134 cell regulation Effects 0.000 description 1
• 230000004656 cell transport Effects 0.000 description 1
• 230000030570 cellular localization Effects 0.000 description 1
• 230000005754 cellular signaling Effects 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 229960002424 collagenase Drugs 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 150000001875 compounds Chemical class 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• 210000004748 cultured cell Anatomy 0.000 description 1
• 230000016396 cytokine production Effects 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 229940104302 cytosine Drugs 0.000 description 1
• 210000004544 dc2 Anatomy 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 238000012217 deletion Methods 0.000 description 1
• 230000037430 deletion Effects 0.000 description 1
• 229960003964 deoxycholic acid Drugs 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 230000000368 destabilizing effect Effects 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
• 239000012153 distilled water Substances 0.000 description 1
• 231100000673 dose–response relationship Toxicity 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 230000005014 ectopic expression Effects 0.000 description 1
• 230000005611 electricity Effects 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 108010078428 env Gene Products Proteins 0.000 description 1
• 210000002615 epidermis Anatomy 0.000 description 1
• DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 201000005884 exanthem Diseases 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 239000013613 expression plasmid Substances 0.000 description 1
• 208000006275 fascioliasis Diseases 0.000 description 1
• 230000002550 fecal effect Effects 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 210000002950 fibroblast Anatomy 0.000 description 1
• 229940126864 fibroblast growth factor Drugs 0.000 description 1
• 230000003890 fistula Effects 0.000 description 1
• 239000012737 fresh medium Substances 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 229940044627 gamma-interferon Drugs 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 201000004946 genital herpes Diseases 0.000 description 1
• 201000006592 giardiasis Diseases 0.000 description 1
• 238000009499 grossing Methods 0.000 description 1
• 230000003394 haemopoietic effect Effects 0.000 description 1
• 201000009277 hairy cell leukemia Diseases 0.000 description 1
• 201000010536 head and neck cancer Diseases 0.000 description 1
• 208000014829 head and neck neoplasm Diseases 0.000 description 1
• 210000002216 heart Anatomy 0.000 description 1
• 208000002672 hepatitis B Diseases 0.000 description 1
• 230000008348 humoral response Effects 0.000 description 1
• 230000001969 hypertrophic effect Effects 0.000 description 1
• 210000003026 hypopharynx Anatomy 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 238000012744 immunostaining Methods 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 239000000411 inducer Substances 0.000 description 1
• 239000012678 infectious agent Substances 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 208000027866 inflammatory disease Diseases 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 229960003786 inosine Drugs 0.000 description 1
• 238000007689 inspection Methods 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 230000010468 interferon response Effects 0.000 description 1
• 230000004073 interleukin-2 production Effects 0.000 description 1
• 201000006675 intestinal schistosomiasis Diseases 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 230000009545 invasion Effects 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 230000001788 irregular Effects 0.000 description 1
• 239000000644 isotonic solution Substances 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 210000002429 large intestine Anatomy 0.000 description 1
• 210000000867 larynx Anatomy 0.000 description 1
• 229940067606 lecithin Drugs 0.000 description 1
• 239000000787 lecithin Substances 0.000 description 1
• 235000010445 lecithin Nutrition 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 210000000088 lip Anatomy 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 210000005228 liver tissue Anatomy 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 210000004379 membrane Anatomy 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 229910021645 metal ion Inorganic materials 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
• 229960003085 meticillin Drugs 0.000 description 1
• 239000010445 mica Substances 0.000 description 1
• 229910052618 mica group Inorganic materials 0.000 description 1
• 239000004005 microsphere Substances 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 239000000178 monomer Substances 0.000 description 1
• 208000030194 mouth disease Diseases 0.000 description 1
• OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 description 1
• 210000003928 nasal cavity Anatomy 0.000 description 1
• 210000001989 nasopharynx Anatomy 0.000 description 1
• 239000006199 nebulizer Substances 0.000 description 1
• 230000019569 negative regulation of cell differentiation Effects 0.000 description 1
• 229940053128 nerve growth factor Drugs 0.000 description 1
• 230000003472 neutralizing effect Effects 0.000 description 1
• 229910052757 nitrogen Inorganic materials 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 229940023146 nucleic acid vaccine Drugs 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 229920001778 nylon Polymers 0.000 description 1
• 229920002113 octoxynol Polymers 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 208000002042 onchocerciasis Diseases 0.000 description 1
• 231100000590 oncogenic Toxicity 0.000 description 1
• 230000002246 oncogenic effect Effects 0.000 description 1
• 210000003300 oropharynx Anatomy 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 238000013021 overheating Methods 0.000 description 1
• 108010071584 oxidized low density lipoprotein Proteins 0.000 description 1
• 208000021090 palsy Diseases 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 208000014837 parasitic helminthiasis infectious disease Diseases 0.000 description 1
• 230000024241 parasitism Effects 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 102000013415 peroxidase activity proteins Human genes 0.000 description 1
• 108040007629 peroxidase activity proteins Proteins 0.000 description 1
• 239000008194 pharmaceutical composition Substances 0.000 description 1
• 210000003800 pharynx Anatomy 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• 229910052698 phosphorus Inorganic materials 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 230000009894 physiological stress Effects 0.000 description 1
• 210000005134 plasmacytoid dendritic cell Anatomy 0.000 description 1
• 201000000317 pneumocystosis Diseases 0.000 description 1
• 102000040430 polynucleotide Human genes 0.000 description 1
• 108091033319 polynucleotide Proteins 0.000 description 1
• 239000002157 polynucleotide Substances 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 238000002731 protein assay Methods 0.000 description 1
• 108020003519 protein disulfide isomerase Proteins 0.000 description 1
• 230000004853 protein function Effects 0.000 description 1
• 230000026447 protein localization Effects 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 230000005855 radiation Effects 0.000 description 1
• 150000003254 radicals Chemical class 0.000 description 1
• 206010037844 rash Diseases 0.000 description 1
• 102000027426 receptor tyrosine kinases Human genes 0.000 description 1
• 108091008598 receptor tyrosine kinases Proteins 0.000 description 1
• 102000005962 receptors Human genes 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• 238000003259 recombinant expression Methods 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 206010038038 rectal cancer Diseases 0.000 description 1
• 201000001275 rectum cancer Diseases 0.000 description 1
• 230000011371 regulation of developmental process Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 208000005687 scabies Diseases 0.000 description 1
• 206010039722 scoliosis Diseases 0.000 description 1
• 206010039766 scrub typhus Diseases 0.000 description 1
• 230000036303 septic shock Effects 0.000 description 1
• 238000013207 serial dilution Methods 0.000 description 1
• 208000017520 skin disease Diseases 0.000 description 1
• FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 1
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 241000894007 species Species 0.000 description 1
• 238000011895 specific detection Methods 0.000 description 1
• 229910001220 stainless steel Inorganic materials 0.000 description 1
• 239000010935 stainless steel Substances 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 238000007619 statistical method Methods 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 230000004936 stimulating effect Effects 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 210000000434 stratum corneum Anatomy 0.000 description 1
• 230000035882 stress Effects 0.000 description 1
• 238000010254 subcutaneous injection Methods 0.000 description 1
• 239000007929 subcutaneous injection Substances 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 108010012704 sulfated glycoprotein p50 Proteins 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 230000003956 synaptic plasticity Effects 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 230000009897 systematic effect Effects 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1
• 230000010474 transient expression Effects 0.000 description 1
• 230000014621 translational initiation Effects 0.000 description 1
• 102000035160 transmembrane proteins Human genes 0.000 description 1
• 108091005703 transmembrane proteins Proteins 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• 239000013638 trimer Substances 0.000 description 1
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
• 238000002604 ultrasonography Methods 0.000 description 1
• 241001529453 unidentified herpesvirus Species 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• 238000011870 unpaired t-test Methods 0.000 description 1
• 230000003827 upregulation Effects 0.000 description 1
• 238000011144 upstream manufacturing Methods 0.000 description 1
• 230000006444 vascular growth Effects 0.000 description 1
• 239000005526 vasoconstrictor agent Substances 0.000 description 1
• 229940126580 vector vaccine Drugs 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 201000001862 viral hepatitis Diseases 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 239000013603 viral vector Substances 0.000 description 1
• 238000012800 visualization Methods 0.000 description 1
• 229940051021 yellow-fever virus Drugs 0.000 description 1